Working Group to Look At Guidelines, Mandates, Centers Role In Prevention, Cancer Control
In Brief: NCI To Push “Cancer Prevention Awareness” This Month; Three RFPs Delayed For Changes
ACS Board Accepts Hammer’s ffer, Will Support Construction Survey
Reexamine Mandates, Samuels Suggests
NIH Considering Intramural NRSA, NCI Advisors Not Enthusiastic
Bloch Pushes PDQ Promotion To Public, But NCAB Limits It to Physicians
Tacoma Hospital Finds Cancer DRGs Are Profitable


Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74
- CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - In the 90s, Barry Kramer persuaded NCI to get out of the business of screening guidelines
At the time, USPSTF was better equipped to do the job. Is it still?









